Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.

    Club de Madrid and the Institute for Climate, Democracy and Inclusion (CDI) have just concluded a mission in Guatemala led by three members of the Club de Madrid: former President of Costa Rica Carlos Alvarado Quesada, former Prime Ministers Kjell Magne Bondevik of Norway and Stefan Löfven of Sweden. Between February 9 and 11, 2026, […] The post Statement by the Club de Madrid and the Institute for Climate, Democracy and Inclusion following an observation mission in Guatemala appeared first on Web-Release.